ArticleAmerican journal of clinical pathology2018

Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.

Winston Y Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.